FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023133839> ?p ?o ?g. }

• W2023133839 endingPage "1300" @default.
• W2023133839 startingPage "1290" @default.
• W2023133839 abstract "We previously identified 9 genes and chromosomal region 3q28 as susceptibility loci for myocardial infarction, ischemic stroke, or chronic kidney disease (CKD) in Japanese individuals by genome-wide or candidate gene association studies. In the present study, we examined the association of 13 polymorphisms at these 10 loci with the prevalence of hypertriglyceridemia, hyper-low-density lipoprotein (LDL) cholesterolemia, hypo-high-density lipoprotein (HDL) cholesterolemia, or CKD in community-dwelling Japanese individuals. The study subjects comprised 6,027 individuals who were recruited to the Inabe Health and Longevity Study, a longitudinal genetic epidemiological study of atherosclerotic, cardiovascular and metabolic diseases. The subjects were recruited from individuals who visited the Health Care Center at Inabe General Hospital for an annual health checkup, and they were followed up each year (mean follow‑up period, 5 years). Longitudinal analysis with a generalized estimating equation and with adjustment for covariates revealed that rs6929846 of butyrophilin, subfamily 2, member A1 gene (BTN2A1) was significantly associated with the prevalence of hypertriglyceridemia (P=0.0001), hyper-LDL cholesterolemia (P=0.0004), and CKD (P=0.0007); rs2569512 of interleukin enhancer binding factor 3 (ILF3) was associated with hyper-LDL cholesterolemia (P=0.0029); and rs2074379 (P=0.0019) and rs2074388 (P=0.0029) of alpha-kinase 1 (ALPK1) were associated with CKD. Longitudinal analysis with a generalized linear mixed-effect model and with adjustment for covariates among all individuals revealed that rs6929846 of BTN2A1 was significantly associated with the serum concentrations of triglycerides (P=0.0011), LDL cholesterol (P=3.3 x 10(-5)), and creatinine (P=0.0006), as well as with the estimated glomerular filtration rate (eGFR) (P=0.0004); rs2569512 of ILF3 was shown to be associated with the serum concentration of LDL cholesterol (P=0.0221); and rs2074379 (P=0.0302) and rs2074388 (P=0.0336) of ALPK1 were shown to be associated with the serum concentration of creatinine. Similar analysis among individuals not taking any anti‑dyslipidemic medication revealed that rs6929846 of BTN2A1 was significantly associated with the serum concentrations of triglycerides (P=8.3 x 10‑5) and LDL cholesterol (P=0.0004), and that rs2569512 of ILF3 was associated with the serum concentration of LDL cholesterol (P=0.0010). BTN2A1 may thus be a susceptibility gene for hypertriglyceridemia, hyper‑LDL cholesterolemia and CKD in Japanese individuals." @default.
• W2023133839 created "2016-06-24" @default.
• W2023133839 creator A5007705218 @default.
• W2023133839 creator A5028242375 @default.
• W2023133839 creator A5038176848 @default.
• W2023133839 creator A5081482638 @default.
• W2023133839 date "2015-03-20" @default.
• W2023133839 modified "2023-10-17" @default.
• W2023133839 title "Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study" @default.
• W2023133839 cites W1570583414 @default.
• W2023133839 cites W1964658354 @default.
• W2023133839 cites W1967490910 @default.
• W2023133839 cites W1972383046 @default.
• W2023133839 cites W1975396627 @default.
• W2023133839 cites W1981064496 @default.
• W2023133839 cites W1981695493 @default.
• W2023133839 cites W1985431557 @default.
• W2023133839 cites W1993799941 @default.
• W2023133839 cites W1994501150 @default.
• W2023133839 cites W1997849573 @default.
• W2023133839 cites W1997981911 @default.
• W2023133839 cites W2000949542 @default.
• W2023133839 cites W2001940689 @default.
• W2023133839 cites W2014862688 @default.
• W2023133839 cites W2025596599 @default.
• W2023133839 cites W2027940065 @default.
• W2023133839 cites W2027952464 @default.
• W2023133839 cites W2028517248 @default.
• W2023133839 cites W2028849019 @default.
• W2023133839 cites W2030069564 @default.
• W2023133839 cites W2033202247 @default.
• W2023133839 cites W2034065282 @default.
• W2023133839 cites W2034222829 @default.
• W2023133839 cites W2051721637 @default.
• W2023133839 cites W2053416557 @default.
• W2023133839 cites W2063680087 @default.
• W2023133839 cites W2070928900 @default.
• W2023133839 cites W2072063634 @default.
• W2023133839 cites W2084067015 @default.
• W2023133839 cites W2085618156 @default.
• W2023133839 cites W2095400574 @default.
• W2023133839 cites W2095746901 @default.
• W2023133839 cites W2096583185 @default.
• W2023133839 cites W2099094969 @default.
• W2023133839 cites W2103660160 @default.
• W2023133839 cites W2105281057 @default.
• W2023133839 cites W2106178155 @default.
• W2023133839 cites W2108120163 @default.
• W2023133839 cites W2113413884 @default.
• W2023133839 cites W2115801316 @default.
• W2023133839 cites W2115931410 @default.
• W2023133839 cites W2117362890 @default.
• W2023133839 cites W2118292923 @default.
• W2023133839 cites W2125886893 @default.
• W2023133839 cites W2130584210 @default.
• W2023133839 cites W2140079333 @default.
• W2023133839 cites W2152189242 @default.
• W2023133839 cites W2153118028 @default.
• W2023133839 cites W2155621934 @default.
• W2023133839 cites W2160180886 @default.
• W2023133839 cites W2161527180 @default.
• W2023133839 cites W2165019590 @default.
• W2023133839 cites W2165238174 @default.
• W2023133839 cites W2169314667 @default.
• W2023133839 cites W2170688007 @default.
• W2023133839 cites W2340325420 @default.
• W2023133839 cites W2475261460 @default.
• W2023133839 cites W2607031541 @default.
• W2023133839 doi "https://doi.org/10.3892/ijmm.2015.2152" @default.
• W2023133839 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4380205" @default.
• W2023133839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25813695" @default.
• W2023133839 hasPublicationYear "2015" @default.
• W2023133839 type Work @default.
• W2023133839 sameAs 2023133839 @default.
• W2023133839 citedByCount "17" @default.
• W2023133839 countsByYear W20231338392015 @default.
• W2023133839 countsByYear W20231338392016 @default.
• W2023133839 countsByYear W20231338392017 @default.
• W2023133839 countsByYear W20231338392018 @default.
• W2023133839 countsByYear W20231338392019 @default.
• W2023133839 countsByYear W20231338392021 @default.
• W2023133839 countsByYear W20231338392022 @default.
• W2023133839 countsByYear W20231338392023 @default.
• W2023133839 crossrefType "journal-article" @default.
• W2023133839 hasAuthorship W2023133839A5007705218 @default.
• W2023133839 hasAuthorship W2023133839A5028242375 @default.
• W2023133839 hasAuthorship W2023133839A5038176848 @default.
• W2023133839 hasAuthorship W2023133839A5081482638 @default.
• W2023133839 hasBestOaLocation W20231338391 @default.
• W2023133839 hasConcept C107130276 @default.
• W2023133839 hasConcept C126322002 @default.
• W2023133839 hasConcept C134018914 @default.
• W2023133839 hasConcept C142724271 @default.
• W2023133839 hasConcept C177860879 @default.
• W2023133839 hasConcept C2776919658 @default.
• W2023133839 hasConcept C2777895361 @default.
• W2023133839 hasConcept C2778096610 @default.
• W2023133839 hasConcept C2778163477 @default.

• next